Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Generics
Manufacturing
Amid ADHD med shortage, AAM spotlights government restrictions
Generics makers are hampered by government limits on producing controlled substances, according to the Association for Accessible Medicines.
Zoey Becker
Nov 20, 2023 11:29am
Viatris gets US agency to review Novo semaglutide patent
Oct 5, 2023 9:10am
Vyvanse, Keytruda-Lenvima, Adagene-ADC—Fierce Pharma Asia
Sep 1, 2023 8:50am
Alkermes grants Teva license to launch generic Vivitrol in 2027
Aug 31, 2023 10:05am
Amid shortage, FDA clears several generics of Takeda's Vyvanse
Aug 30, 2023 2:27pm
Shionogi, Takeda, AbbVie-BeiGene—Fierce Pharma Asia
Jun 30, 2023 9:45am
